GW Pharma seeks FDA approval for cannabis drug

As reported by the Daily Mail, the UK pharmaceutical company, GW Pharma is currently seeking approval from the US Food and Drug Administration (FDA) for their cannabis-based drug.

The drug, which is a mouth spray called Sativex is made from raw marijuana and is used to treat cancer pain. The drug is currently in advanced clinical trials and GW Pharma hope to receive approval by the end of the year.

Sativex is the first of it’s kind which is derived from raw marijuana – previous drugs have  used the synthetic alternatives. It contains two of marijuana’s best known components – delta 9 and cannabidiol. It ahs already been approved in New Zealand, Canada and eight European countries for the treatment of muscle spasms associated with multiple sclerosis.

Click here to search our current pharmaceutical jobs online now.

Posted in: General, News
CK Logo in place of featured image